1-20 of 405
cardiotoxicity
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic Effect of Carfilzomib and Metformin in Vascular Plasticity; The Emerging Role of Autophagy

Panagiotis Efentakis, PhD, Ioanna Andreadou, PhD, Panagiota-Efstathia Nikolaou, PhD, Claudius Witzler, Svenja Siemer, Eftathios Kastritis, Philip Wenzel, MD PhD, Meletios A. Dimopoulos, MD, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3797.
https://doi.org/10.1182/blood-2019-123522
Published: 2019
Journal Articles

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia

Laura Agresta, MD, Maureen M O'Brien, MD, Kana Mizuno, PhD, Robin Norris, MD MS, MPH, Erin H. Breese, MD PhD, Christine L Phillips, MD, Karen Burns, MD, Benjamin Mizukawa, Lynn Lee, MD, Adam Lane, PhD, Robert B. Lorsbach, MD PhD, Thomas D. Ryan, MD PhD, Pankaj B. Desai, PhD, Alexander A. Vinks, PharmD, PhD, H. Leighton Grimes, PhD, John P Perentesis, Michael J. Absalon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3830.
https://doi.org/10.1182/blood-2019-121514
Published: 2019
Journal Articles

Genetic Risk Factors for Cardiovascular Disease in Adult Lymphoma Patients

Sunnia T Chen, BS, Nicholas J Boddicker, PhD, Matthew J. Maurer, MS, Cristine Allmer, BS, Dennis P. Robinson, Grzegorz Nowakowski, MD, Thomas M. Habermann, MD, Susan L Slager, PhD, Carrie A. Thompson, MD, James R. Cerhan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5215.
https://doi.org/10.1182/blood-2019-128775
Published: 2019
Journal Articles

Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review

Maimoona Khan, MBBS, Asma Waheed, MBBS, Rida Ul Jannat, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhaddis Ejaz Ahmad, MD, Muhammad Abdullah Yousaf, MBBS, MD, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Sravanthi Kotapati, MBBS, Irbaz Riaz, MDMMSc, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5588.
https://doi.org/10.1182/blood-2019-128833
Published: 2019
Journal Articles

Carfilzomib-Pomalidomide-Dexamethasone (KPD) in Relapsed/Refractory Multiple Myeloma Patients - an Institutional Retrospective Analysis

Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Mohan Bhaarat, Sumeet Prakash Mirgh, MBBS, MDDM, Vishvdeep Khushoo, MBBS, MDDM, Shinto Francis Thekuddan, MBBS, MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5572.
https://doi.org/10.1182/blood-2019-131674
Published: 2019
Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5688.
https://doi.org/10.1182/blood-2019-127680
Published: 2019
Journal Articles

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

Timothy Devos, MD PhD, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Alain Gadisseur, Gaëtan Vanstraelen, Marc André, Benjamin Bailly, Nikki Granacher, Philippe Lewalle, Ann De Becker, Koen Van Eygen, Marie Lejeune, Dries Deeren, MD PhD, Gianfilippo Nifosi, Agnes Triffet, Inge Vrelust, Julie Bekaert, Michael Beck, Dominik Selleslag
Journal: Blood
Blood (2019) 134 (Supplement_1): 4161.
https://doi.org/10.1182/blood-2019-127923
Published: 2019
Journal Articles

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

Chloe Pek Sang Tang, MBBS, FRACP, Andre La Gerche, Julie McMullen, BSc(Hons) PhDFCSANZ FAHA, Erin Howden, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Isaac Goncalves, MBBS PhDFRACP, Jenny Ooi, Constantine S. Tam, MBBS (Hons), MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4301.
https://doi.org/10.1182/blood-2019-129808
Published: 2019
Journal Articles

Preliminary Results of CML1214, a Survey on Ponatinib Compassionate Use in Italy By the Gimema CML Working Party

Carmen Fava, Matteo Emidio Dragani, MD, Paola Boggione, Francesca Paoloni, Luigiana Luciano, Antonella Gozzini, MD, Patrizia Pregno, Elisabetta Abruzzese, MD, Carlo Gambacorti-Passerini, MD, Giorgina Specchia, MD, Chiara Elena, MD, Monia Lunghi, MD, Ester Pungolino, Franca Falzetti, MD, Sara Galimberti, MD PhD, Alessandra Iurlo, MD PhD, Giovanni D'Arena, MD, Giovanni Reddiconto, Claudio Fozza, MD, Micaela Bergamaschi, MD, Enrico Crea, Giuseppe Saglio, MD, Giovanna Rege Cambrin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2931.
https://doi.org/10.1182/blood-2019-125052
Published: 2019
Journal Articles

Ten-Year Follow-up of Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line: Final Results of the Gimema CML 0307 Trial

Gabriele Gugliotta, MD PhD, Fausto Castagnetti, MD PhD, Massimo Breccia, MD, Luciano Levato, MD, Tamara Intermesoli, MD, Mariella D'adda, Marzia Salvucci, MD, Fabio Stagno, MD, Giovanna Rege Cambrin, MD PhD, Mario Tiribelli, Bruno Martino, MD, Monica Bocchia, Elena Trabacchi, MD, Francesco Cavazzini, MD, Ferdinando Porretto, Federica Sorà, MD, Giovanni Caocci, MD, Francesco Albano, MD, Giovanni Martinelli, MD, Simona Soverini, PhD, Robin Foà, MD, Fabrizio Pane, MD, Michele Cavo, Giuseppe Saglio, MD, Michele Baccarani, MD, Gianantonio Rosti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4145.
https://doi.org/10.1182/blood-2019-126163
Published: 2019
Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4578.
https://doi.org/10.1182/blood-2019-129095
Published: 2019
Journal Articles

Carfilzomib Induces Cardiotoxicity Via ß5/ß2-Specific Proteasome Subunit Inhibition Pattern

Max A Mendez-Lopez, MD, Andrej Besse, PhD, Bogdan Florea, PhD, Christian Zuppinger, PhD, Herman Overkleeft, PhD, Christoph Driessen, MD, Lenka Besse, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3110.
https://doi.org/10.1182/blood-2019-127987
Published: 2019
Journal Articles

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Ahmed Toure, BA, Yiyuan Wu, MS, Paul J Christos, Dr.P.H., M.S., Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2205.
https://doi.org/10.1182/blood-2019-131567
Published: 2019
Journal Articles

Daratumumab Monotherapy in Previously Untreated High-Risk Patients with Stage 3B Light Chain (AL) Amyloidosis: A Phase II Multicenter Study By European Myeloma Network (EMN)

Eftathios Kastritis, Monique C. Minnema, Meletios A. Dimopoulos, MD, Giampaolo Merlini, MD, Pieter Sonneveld, Giovanni Palladini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1868.
https://doi.org/10.1182/blood-2019-126524
Published: 2019
Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1592.
https://doi.org/10.1182/blood-2019-124382
Published: 2019
Journal Articles

Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia

Shiwei Yang, Zunmin Zhu, Xiaojian Zhu, Yicheng Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5088.
https://doi.org/10.1182/blood-2019-128602
Published: 2019
Journal Articles

Using Pharmacogenomics Testing to Optimize Care in Children with Acute Hematologic Malignancies

Trisha Kissoon, MD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5062.
https://doi.org/10.1182/blood-2019-129511
Published: 2019
Journal Articles

Clinical Efficacy of L-Annamycin, a Liposomal Formulated Non-Cross-Resistant and Non-Cardiotoxic Anthracycline in Relapsed/Refractory AML Patients

Lidia Gil, MD PhD, Robert C. Shepard, MD, Sandra L Silberman, MD PhD, Ewa Maria Zak, MSc, Waldemar Priebe, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5147.
https://doi.org/10.1182/blood-2019-129268
Published: 2019
Journal Articles

Biodistribution and Efficacy of L-Annamycin in a Novel Imageable AML Mouse Model

Rafal Zielinski, PhD, Krzysztof Grela, PhD, Stanislaw Skora, PhD, Rodrigo Jacamo, PhD, Izabela Fokt, PhD, Matthew Sander, Magdalena Remiszewski, PhD, Edward Felix, PhD, Meenakshi Shanmugasundaram, Malgorzata Anna Zal, MSc, Michael Andreeff, MD PhD, Waldemar Priebe, PhD, Tomasz Zal, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5150.
https://doi.org/10.1182/blood-2019-131977
Published: 2019
Journal Articles

Cost Effective Cardio Protective Intervention in Haploidentical Hematopoietic Stem Cell Transplantation in Children - a Study from a Tertiary Care Centre in India

Revathi Raj, Ramya Uppuluri, MD, Venkateswaran Vellaichamy, MD, Nikila Ravichandran, MD, Kesavan Melarkode Ramanan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5866.
https://doi.org/10.1182/blood-2019-131539
Published: 2019